NL7301936A - - Google Patents

Info

Publication number
NL7301936A
NL7301936A NL7301936A NL7301936A NL7301936A NL 7301936 A NL7301936 A NL 7301936A NL 7301936 A NL7301936 A NL 7301936A NL 7301936 A NL7301936 A NL 7301936A NL 7301936 A NL7301936 A NL 7301936A
Authority
NL
Netherlands
Application number
NL7301936A
Other versions
NL179026C (nl
NL179026B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7301936A publication Critical patent/NL7301936A/xx
Publication of NL179026B publication Critical patent/NL179026B/xx
Application granted granted Critical
Publication of NL179026C publication Critical patent/NL179026C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NLAANVRAGE7301936,A 1972-03-01 1973-02-12 Werkwijze ter bereiding van een geneesmiddel met als actieve verbinding een 2-alkylamino 4'-methyl 4-piperazino-5-thiopyrimidineverbinding en werkwijze voor de bereiding van de actieve verbinding. NL179026C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7206981A FR2173746B1 (https=) 1972-03-01 1972-03-01

Publications (3)

Publication Number Publication Date
NL7301936A true NL7301936A (https=) 1973-09-04
NL179026B NL179026B (nl) 1986-02-03
NL179026C NL179026C (nl) 1986-07-01

Family

ID=9094373

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7301936,A NL179026C (nl) 1972-03-01 1973-02-12 Werkwijze ter bereiding van een geneesmiddel met als actieve verbinding een 2-alkylamino 4'-methyl 4-piperazino-5-thiopyrimidineverbinding en werkwijze voor de bereiding van de actieve verbinding.

Country Status (14)

Country Link
US (1) US3843656A (https=)
JP (1) JPS5416510B2 (https=)
AR (1) AR195597A1 (https=)
BE (1) BE796114A (https=)
CA (1) CA977756A (https=)
CH (1) CH556858A (https=)
DE (1) DE2307536C3 (https=)
DK (1) DK130978B (https=)
ES (1) ES412182A1 (https=)
FR (1) FR2173746B1 (https=)
GB (1) GB1363047A (https=)
NL (1) NL179026C (https=)
NO (1) NO137236C (https=)
SE (1) SE398750B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2281117A2 (fr) * 1974-08-09 1976-03-05 Ugine Kuhlmann Nouvelles piperazino-pyrimidines utilisables comme medicaments
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
NL7605319A (nl) * 1975-05-23 1976-11-25 Mar Pha Etu Expl Marques Werkwijze ter bereiding van een geneesmiddel, zo gevormd geneesmiddel en werkwijze ter bereiding van geschikte geneeskrachtige verbindingen.
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
DE3417264A1 (de) * 1984-05-10 1985-11-14 Bayer Ag, 5090 Leverkusen Neue 2,4-diamino-6-halogen-5-alkylthio-pyrimidine
CA2217034A1 (en) * 1995-04-03 1996-10-10 Sumitomo Pharmaceuticals Company, Limited Novel pyrimidine derivatives effective as psychotropic drug and process for the production thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
DK130978B (da) 1975-05-12
DE2307536C3 (de) 1980-03-06
NO137236C (no) 1978-01-25
GB1363047A (en) 1974-08-14
DK130978C (https=) 1975-10-13
CA977756A (en) 1975-11-11
FR2173746B1 (https=) 1975-04-25
NO137236B (no) 1977-10-17
DE2307536B2 (de) 1979-06-28
AR195597A1 (es) 1973-10-23
SE398750B (sv) 1978-01-16
JPS5416510B2 (https=) 1979-06-22
NL179026C (nl) 1986-07-01
FR2173746A1 (https=) 1973-10-12
US3843656A (en) 1974-10-22
JPS4899185A (https=) 1973-12-15
BE796114A (fr) 1973-08-28
CH556858A (fr) 1974-12-13
DE2307536A1 (de) 1973-09-13
NL179026B (nl) 1986-02-03
ES412182A1 (es) 1976-01-01

Similar Documents

Publication Publication Date Title
DK130978C (https=)
JPS4991840A (https=)
CH575193A5 (https=)
BE789487A (https=)
BG17679A1 (https=)
BG18009A1 (https=)
BG18065A1 (https=)
BG18068A1 (https=)
BG18232A1 (https=)
BG18502A1 (https=)
BG18751A1 (https=)
BG20209A1 (https=)
BG20644A1 (https=)
BG21228A3 (https=)
BG21608A3 (https=)
CH1071572A4 (https=)
CH545899A (https=)
CH555929A (https=)
CH559906A5 (https=)
CH560639A5 (https=)
CH561531A5 (https=)
CH561994A5 (https=)
CH562033A5 (https=)
CH562099A5 (https=)
CH562900A5 (https=)

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee